10-K · February 23, 2026
Novanta reports FY2025 revenue of $980.6 million (Automation Enabling Technologies $500.8M; Medical Solutions $479.8M) with backlog up to $481.2 million from $445.5 million a year earlier. The company strengthened…
Earnings analysis · 10-Q
NOVT earnings analysis
Filed May 11, 2026 · Our reading of the company's report
The latest report
Novanta Inc. reported Q1 2026 results with total revenue of $257.7 million, up 10.4% year-over-year, and diluted EPS at $0.51, a decrease from the prior year's $0.59. Segment performance showed strong growth in the…
Read full summary
Novanta Inc. reported Q1 2026 results with total revenue of $257.7 million, up 10.4% year-over-year, and diluted EPS at $0.51, a decrease from the prior year's $0.59. Segment performance showed strong growth in the Medical Solutions segment, which increased by 14.8%, while Automation Enabling Technologies rose by 6.6%. Operating income decreased to $27.5 million due to higher SG&A and restructuring costs.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
From revenue to operating profit
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
Where revenue came from
The business segments reported by the company.
Shares of the segments disclosed in this filing, largest first.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $0.51
What stood out
-
Revenue Growth
Total revenue reached $257.7 million, a 10.4% increase from the prior year.
-
Medical Segment Strength
Medical Solutions revenue increased by $16.3 million or 14.8% from last year.
-
Improved EPS
Q1 EPS of $0.51 decreased from $0.59, but was above consensus of $0.78.
-
Cash Flow Increase
Operating cash flow improved to $51.6 million from $31.7 million year-over-year.
-
Debt Levels Reduced
Net interest expense decreased to $1.8 million from $5.6 million, reflecting lower average debt.
-
Strong Liquidity
Cash and cash equivalents increased to $388.8 million from $380.9 million.
What to watch
-
Increased Operating Costs
Operating income fell 15.1% to $27.5 million due to increasing expenses.
-
Margin Compression
Gross margin decreased to 44.1% from 44.7% due to higher material and tariff costs.
-
Geopolitical and Economic Risks
Weakening market demand due to geopolitical tensions may adversely affect revenue.
Management's outlook
For FY 2026, management anticipates revenue between $1.040 billion and $1.055 billion.
Earlier filings 4
10-Q · August 5, 2025
Novanta reported Q2 revenue of $241.05M, up 2.2% year-over-year and 3.4% sequentially, but operating profit and EPS compressed due to elevated acquisition and restructuring costs and FX losses. Balance sheet shows…
10-Q · May 6, 2025
Novanta reported Q1 revenue of $233,366,000, up $2,450,000 versus Q1 2024, with gross profit of $104,354,000 (44.7% margin) and operating income of $32,421,000 (13.9% margin). Diluted EPS was $0.59 versus $0.41 a year…
10-Q · November 5, 2024
Novanta reported Q3 revenue of $244.405 million, up $22.902 million (+10.3%) versus Q3 2023, with gross profit of $109.215 million. Operating income rose to $32.555 million but diluted EPS fell to $0.53 from $0.59 a…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.